60 results
Page 3 of 3
F-1
674t5uy8klj ahlp
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.13
r5yzv9jjchl xxfk
24 Jun 19
Registration statement (foreign)
4:04pm
6-K
EX-99.1
w7itr39kc da8zfh94x
5 Jun 19
Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer
2:43pm
6-K
EX-99.1
16j g40mum7
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.3
gf1k w8ibbffr3q
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.1
2v461pcr wz
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
20-F
r7i4 zla060i
25 Feb 19
Annual report (foreign)
5:08pm
20-F
EX-4.13
al17myl5
25 Feb 19
Annual report (foreign)
5:08pm
6-K
EX-99.1
53caaw
25 Feb 19
Gamida Cell Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
4:15pm
6-K
EX-99.1
egp0tjw
21 Feb 19
Current report (foreign)
2:06pm
6-K
EX-99.1
mvn54dqt7xefv
19 Feb 19
Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
2:05pm
DRS
b8c4r9wo2
15 Feb 19
Draft registration statement
12:00am
6-K
EX-99.1
vci2fz3l
8 Feb 19
Current report (foreign)
9:50am
6-K
EX-99.1
wucv6
25 Jan 19
Gamida Cell Announces Data from NAM-NK and NiCord® Programs to Be Presented at 2019 TCT Annual Meeting
12:22pm
6-K
EX-99.1
uc4l0zfqji3ba
7 Jan 19
Gamida Cell Announces 2019 Goals and Provides Company Update
4:25pm
424B4
6x4ld9mz
30 Oct 18
Prospectus supplement with pricing info
8:35am
F-1/A
bud0irbg6nvno0atl
17 Oct 18
Registration statement (foreign) (amended)
6:06am
F-1
mf3a9r0
28 Sep 18
Registration statement (foreign)
4:29pm
DRS/A
ylmrej58aoiaxjmx
3 Jul 18
Draft registration statement (amended)
12:00am
DRS
b5v195qn 8z1tlcpy8h5
1 Jun 18
Draft registration statement
12:00am